APA (7th ed.) Citation

Halstenson, C. E., Shamp, T., Gargano, M. A., Walsh, R. M., & Patchen, M. L. (2016). Two randomized, double-blind, placebo-controlled, dose-escalation phase 1 studies evaluating BTH1677, a 1, 3–1,6 beta glucan pathogen associated molecular pattern, in healthy volunteer subjects. Investigational new drugs, 34(2), 202-215. https://doi.org/10.1007/s10637-016-0325-z

Chicago Style (17th ed.) Citation

Halstenson, C. E., T. Shamp, M. A. Gargano, R. M. Walsh, and M. L. Patchen. "Two Randomized, Double-blind, Placebo-controlled, Dose-escalation Phase 1 Studies Evaluating BTH1677, a 1, 3–1,6 Beta Glucan Pathogen Associated Molecular Pattern, in Healthy Volunteer Subjects." Investigational New Drugs 34, no. 2 (2016): 202-215. https://doi.org/10.1007/s10637-016-0325-z.

MLA (9th ed.) Citation

Halstenson, C. E., et al. "Two Randomized, Double-blind, Placebo-controlled, Dose-escalation Phase 1 Studies Evaluating BTH1677, a 1, 3–1,6 Beta Glucan Pathogen Associated Molecular Pattern, in Healthy Volunteer Subjects." Investigational New Drugs, vol. 34, no. 2, 2016, pp. 202-215, https://doi.org/10.1007/s10637-016-0325-z.